NCT04716725View on ClinicalTrials.gov

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

April 30, 2025

Conditions
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8
Interventions
DRUG

68Ga-PSMA-11

Given IV

PROCEDURE

Positron Emission Tomography (PET)

Undergo PET

Trial Locations (1)

94143

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

Conquer Cancer Foundation

OTHER

collaborator

Gateway for Cancer Research

OTHER

collaborator

Prostate Cancer Foundation

OTHER

lead

Thomas Hope

OTHER